Monday, December 05, 2011 « Back
Teva to Present at the NASDAQ OMX 27th Investor Program

JERUSALEM--(BUSINESS WIRE)--Dec. 5, 2011-- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the NASDAQ OMX 27th Investor Program with Eyal Desheh, Chief Financial Officer, Teva Pharmaceutical Industries Ltd., presenting on Tuesday, December 6, 2011 in London.

What:

  Teva Presentation at the NASDAQ OMX 27th Investor Program
 

Who:

Eyal Desheh, Chief Financial Officer, Teva Pharmaceutical Industries Ltd.
 

When:

Tuesday, December 6, 2011 at 5:15 am EST (10:15 am GMT)
 

Where:

http://investor.shareholder.com/NDQCCG/london_dec2011/eventdetail.cfm?eventid=105938

 

How:

Live over the Internet – log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva’s website.

About Teva

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,300 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 45,000 people around the world and reached $16.1 billion in net sales in 2010.

Source: Teva Pharmaceutical Industries Ltd.

IR:
Teva Pharmaceutical Industries Ltd.
Elana Holzman, 972 (3) 926-7554
or
Teva North America
Kevin C. Mannix, 215-591-8912
or
PR:
Teva Pharmaceutical Industries Ltd.
Yossi Koren, 972 (3) 926-7687
or
Teva North America
Denise Bradley, 215-591-8974